UNSPSC 51282501: Cefacetrile or cephacetrile

This classification denotes an anti-bacterial agent with the molecular formula C13H13N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FDM21QQ344, chemically known as (6r,7r)-3-acetoxymethyl-7-(2-cyanacetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure but generally known as cefacetrile, which bears US NIH Compound Identifier 91562. Cefacetrile most often comes in base and sodium forms.

UNSPSC 51282501 Cefacetrile or cephacetrile is a Commodity code that shows minimal relevant recent activity under its nominal scope. The four most recent state and local opportunities tagged to this code involve naloxone and drug deactivation systems, therapeutic pharmacy initiatives, emergency medical and first aid supplies, and generic multi-source pharmaceuticals and OTC products — none of which are cephalosporin antibiotics or cefacetrile formulations. The mismatch suggests either systematic miscoding in state and local procurement systems or that the code is applied too broadly to capture pharmaceutical procurement generally rather than the specific antibiotic class it nominally describes. State and local buyers appear to be using pharmaceutical procurement codes to flag a wide range of health-related product sourcing rather than narrow product lines.

The issuing bodies across these opportunities span state health and human services commissions (Texas HHS), multistate cooperative purchasing alliances (Minnesota MMCAP), county health departments (Seminole County, Florida), and municipal fire rescue divisions (City of Tampa), reflecting the fragmented nature of pharmaceutical procurement across state and local jurisdictions. Recent activity concentrates in Florida, Minnesota, and Texas, with the Minnesota MMCAP cooperative purchasing vehicle notably structured to serve multiple states including Oregon. Representative opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023), the City of Tampa's IFB for medical and first aid supplies with an estimated contract value of $700,000 and a Small Local Business Enterprise set-aside (due March 13, 2026), Minnesota MMCAP's RFP for generic pharmaceuticals and OTC products (due March 26, 2026), and Texas HHS's RFI on direct-to-manufacturer prescription programs (response deadline April 3, 2026). The code does not support procurement activity specifically for cefacetrile or related cephalosporin antibiotics.